Prince Joshua S. 4
4 · Vistagen Therapeutics, Inc. · Filed Jul 2, 2024
Insider Transaction Report
Form 4
Prince Joshua S.
Chief Operating Officer
Transactions
- Award
Common Stock
2024-06-28$2.96/sh+2,671$7,901→ 2,671 total
Footnotes (1)
- [F1]Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan, as amended.